Kimelman & Baird’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.01M | Hold |
14,240
| – | – | 0.41% | 44 |
|
|
2025
Q4 | $4.66M | Hold |
14,240
| – | – | 0.36% | 44 |
|
|
2025
Q3 | $4.02M | Sell |
14,240
-550
| -4% | -$160K | 0.31% | 44 |
|
|
2025
Q2 | $4.13M | Sell |
14,790
-10
| -0.1% | -$2.83K | 0.34% | 45 |
|
|
2025
Q1 | $4.61M | Hold |
14,800
| – | – | 0.39% | 42 |
|
|
2024
Q4 | $3.86M | Sell |
14,800
-1,500
| -9% | -$445K | 0.31% | 46 |
|
|
2024
Q3 | $5.25M | Sell |
16,300
-100
| -0.6% | -$32.7K | 0.42% | 44 |
|
|
2024
Q2 | $5.12M | Buy |
+16,400
| New | +$4.82M | 0.42% | 41 |
|
|
2021
Q2 | $877K | Buy |
+3,600
| New | +$886K | 0.08% | 66 |
|
|
2019
Q3 | $697K | Hold |
3,600
| – | – | 0.1% | 64 |
|
|
2019
Q2 | $663K | Hold |
3,600
| – | – | 0.09% | 67 |
|
|
2019
Q1 | $684K | Hold |
3,600
| – | – | 0.1% | 65 |
|
|
2018
Q4 | $701K | Hold |
3,600
| – | – | 0.11% | 64 |
|
|
2018
Q3 | $746K | Hold |
3,600
| – | – | 0.09% | 69 |
|
|
2018
Q2 | $665K | Buy |
+3,600
| New | +$637K | 0.09% | 71 |
|
|
2017
Q4 | $626K | Hold |
3,600
| – | – | 0.09% | 74 |
|
|
2017
Q3 | $671K | Hold |
3,600
| – | – | 0.1% | 72 |
|
|
2017
Q2 | $620K | Hold |
3,600
| – | – | 0.09% | 76 |
|
|
2017
Q1 | $591K | Hold |
3,600
| – | – | 0.09% | 77 |
|
|
2016
Q4 | $526K | Hold |
3,600
| – | – | 0.09% | 77 |
|
|
2016
Q3 | $601K | Hold |
3,600
| – | – | 0.11% | 72 |
|
|
2016
Q2 | $548K | Hold |
3,600
| – | – | 0.1% | 72 |
|
|
2016
Q1 | $540K | Hold |
3,600
| – | – | 0.1% | 75 |
|
|
2015
Q4 | $584K | Buy |
+3,600
| New | +$566K | 0.11% | 77 |
|
|
2015
Q2 | $553K | Buy |
3,600
+600
| +20% | +$96.1K | 0.09% | 82 |
|
|
2015
Q1 | $480K | Hold |
3,000
| – | – | 0.09% | 82 |
|
|
2014
Q4 | $478K | Hold |
3,000
| – | – | 0.09% | 84 |
|
|
2014
Q3 | $421K | Hold |
3,000
| – | – | 0.08% | 84 |
|
|
2014
Q2 | $355K | Sell |
3,000
-150
| -5% | -$17.4K | 0.06% | 92 |
|
|
2014
Q1 | $389K | Hold |
3,150
| – | – | 0.07% | 83 |
|
|
2013
Q4 | $359K | Hold |
3,150
| – | – | 0.07% | 87 |
|
|
2013
Q3 | $353K | Hold |
3,150
| – | – | 0.07% | 87 |
|
|
2013
Q2 | $311K | Buy |
+3,150
| New | +$327K | 0.07% | 86 |
|
Other funds holding AMGN
VCM
VPM
Kimelman & Baird's AMGN Position: Q1 2026 in Review
Kimelman & Baird held its Amgen (AMGN) position steady in Q1 2026 at 14,240 shares worth $5.01M. The position accounts for 0.41% of the portfolio, ranked #44.
Kimelman & Baird first reported a position in AMGN in Q2 2013 and has held it in 33 quarters since. The position peaked at $5.25M in Q3 2024. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Kimelman & Baird held 14,240 shares of Amgen worth $5.01M as of Q1 2026.
- Kimelman & Baird left its Amgen share count unchanged in Q1 2026.
- Amgen made up 0.41% of Kimelman & Baird's portfolio in Q1 2026, its #44 holding.
- Kimelman & Baird first reported a position in Amgen in Q2 2013 and has held it in 33 quarters since.
- Kimelman & Baird's Amgen position peaked at $5.25M in Q3 2024.
- 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Kimelman & Baird's 13F filing for Q1 2026, filed 13 May 2026.